Literature DB >> 1417492

A randomized clinical trial comparing two methods of fascia closure following midline laparotomy.

J B Trimbos1, I B Smit, J P Holm, J Hermans.   

Abstract

Three hundred forty women undergoing midline laparotomy were randomized into an interrupted suture (polyglactin 910, size 1) or a continuous suture (polyglyconate, size 0) closure group. The two groups were well balanced with respect to various risk factors for postoperative wound complications. Early evaluation revealed no differences between the continuous and interrupted suture groups with respect to wound infection (3% vs 1%), superficial wound dehiscence (2% vs 4%), and deep wound dehiscence (0.6% vs 0%). Late evaluation showed no differences between the two groups either. Continuous polyglyconate and interrupted polyglactin 910 sutures had a similar incidence of suture fistula (0% vs 2%), wound pain (1% vs 2%), and incisional hernia (3% vs 4%). Continuous closure was done faster and resulted in less foreign-body suture material. Despite its smaller diameter, the polyglyconate suture also retains a higher tensile strength after surgery than does the quicker-degrading polyglactin 910 suture. Results of this study lead to the conclusion that a running polyglyconate suture is the better choice for closure of the abdominal-wall fascia following midline laparotomy.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1417492     DOI: 10.1001/archsurg.1992.01420100094016

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  14 in total

1.  Outcome of and risk factors for incisional hernia after partial hepatectomy.

Authors:  Shinji Togo; Yasuhiko Nagano; Chizuru Masumoto; Hideki Takakura; Kenichi Matsuo; Kazuhisa Takeda; Kuniya Tanaka; Itaru Endo; Hiroshi Shimada
Journal:  J Gastrointest Surg       Date:  2008-01-23       Impact factor: 3.452

2.  Automatic Segmentation of Abdominal Wall in Ventral Hernia CT: A Pilot Study.

Authors:  Zhoubing Xu; Wade M Allen; Benjamin K Poulose; Bennett A Landman
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2013-03-13

3.  Texture analysis improves level set segmentation of the anterior abdominal wall.

Authors:  Zhoubing Xu; Wade M Allen; Rebeccah B Baucom; Benjamin K Poulose; Bennett A Landman
Journal:  Med Phys       Date:  2013-12       Impact factor: 4.071

4.  A prospective evaluation of the risk factors for development of wound dehiscence and incisional hernia.

Authors:  Kerim Bora Yılmaz; Melih Akıncı; Lütfi Doğan; Niyazi Karaman; Cihangir Özaslan; Can Atalay
Journal:  Ulus Cerrahi Derg       Date:  2013-03-01

5.  Immersive Virtual Reality for Visualization of Abdominal CT.

Authors:  Qiufeng Lin; Zhoubing Xu; Bo Li; Rebeccah Baucom; Benjamin Poulose; Bennett A Landman; Robert E Bodenheimer
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2013-03-28

6.  The search for an ideal method of abdominal fascial closure: a meta-analysis.

Authors:  N C Hodgson; R A Malthaner; T Ostbye
Journal:  Ann Surg       Date:  2000-03       Impact factor: 12.969

7.  Epidemiology and cost of ventral hernia repair: making the case for hernia research.

Authors:  B K Poulose; J Shelton; S Phillips; D Moore; W Nealon; D Penson; W Beck; M D Holzman
Journal:  Hernia       Date:  2011-09-09       Impact factor: 4.739

Review 8.  Ventral hernia repair with synthetic mesh in a contaminated field: a systematic review and meta-analysis.

Authors:  M P Morris; J A Mellia; A N Christopher; M N Basta; V Patel; K Qiu; R B Broach; J P Fischer
Journal:  Hernia       Date:  2021-01-19       Impact factor: 4.739

9.  Quantitative Anatomical Labeling of the Anterior Abdominal Wall.

Authors:  Wade M Allen; Zhoubing Xu; Andrew J Asman; Benjamin K Poulose; Bennett A Landman
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2013-03-28

10.  Concomitant open ventral hernia repair: what is the financial impact of performing open ventral hernia with other abdominal procedures concomitantly?

Authors:  Vashisht Madabhushi; Margaret A Plymale; John Scott Roth; Sara Johnson; Alex Wade; Daniel L Davenport
Journal:  Surg Endosc       Date:  2017-10-19       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.